RxDoctor Payments DataLook up a doctor →

Adam Wisor

Adult Health · du Bois, PANPI 1932480167

Payments from drug & device makers

$11,573in general payments, 2019–2025

Across 648 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$770
  • Incyte Corporation$704
  • Johnson & Johnson$683
  • Novartis$644
  • Merck$569
  • Takeda Pharmaceuticals U.S.A., Inc.$561
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Daiichi Sankyo Inc.40$770
Incyte Corporation44$704
Johnson & Johnson(2 entities)37$683
Novartis36$644
Merck32$569
Takeda Pharmaceuticals U.S.A., Inc.25$561
Pfizer32$543
AstraZeneca(2 entities)27$528
Eisai Inc.27$425
AbbVie26$406
GSK21$392
Seagen Inc.17$349
Amgen14$300
E.r. Squibb & Sons, L.L.C.20$296
Lilly USA, LLC15$291
Genentech USA, Inc.16$256
AVEO Pharmaceuticals, Inc.10$252
Bristol Myers Squibb19$236
Sanofi12$234
Exelixis Inc.21$218
Rigel Pharmaceuticals, Inc.17$214
Ipsen Biopharmaceuticals, Inc11$213
Regeneron Healthcare Solutions, Inc.9$195
Astellas Pharma US Inc6$181
Geron Corporation2$167
Sumitomo Pharma America, Inc.10$166
ADC Therapeutics America, Inc.7$134
Pharmaessentia USA Corporation5$127
Taiho Oncology, Inc.6$113
Array Biopharma Inc7$109
Blueprint Medicines Corporation6$100
Tolmar, Inc.5$94
Jazz Pharmaceuticals Inc.4$77
Beigene USA, Inc.5$76
Pharmacosmos Therapeutics Inc.3$75
Tersera Therapeutics LLC4$72
Syndax Pharmaceuticals, Inc.3$58
Tactile Systems Technology Inc4$56
Karyopharm Therapeutics Inc.3$53
EMD Serono, Inc.3$51
Gilead3$49
Genmab U.S., Inc.3$48
Stemline Therapeutics Inc.3$46
Sobi, Inc3$44
Boehringer Ingelheim2$40
Bayer2$37
Springworks Therapeutics, Inc.2$36
Morphosys, US Inc.2$31
Foundation Medicine, Inc.2$29
Beone Medicines USA, Inc.2$29
Mirati Therapeutics, Inc.2$28
Acrotech Biopharma Inc.2$27
Puma Biotechnology, Inc.2$26
Myriad Genetic Laboratories, Inc.1$22
Deciphera Pharmaceuticals Inc.1$18
Coherus Oncology, Inc.1$17
Myovant Sciences Inc.1$16
Novocure Inc.1$15
Pharmaand GmbH1$14
Acceleron Pharma, Inc.1$13

How this compares

$11,573 in reported general payments places this provider in the 95th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$36,173
Medicare patients
147
Services billed
444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in du Bois

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →